Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view
Background Since December 2019, the newly emerged SARS-CoV-2 virus continues to infect humans and many people died from severe Covid-19 during the last 2 years worldwide. Different approaches are being used for treatment of this infection and its consequences, but limited results have been achieved...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1865; no. 11; p. 129974 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.11.2021
Published by Elsevier B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!